Karen Hunady | Director, IR and Corporate Communications |
Nancy Simonian | President and CEO |
David Roth | CMO |
Jason Haas | CFO |
Conley Chee | CCOO |
Ted Tenthoff | Piper Sandler |
Phil Nadeau | TD Cowen |
Good morning, and welcome to Syros Pharmaceuticals' Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in listen only mode. This call is being webcast live on the Investors and Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded.
At this time, I would like to turn the call over to Karen Hunady, Director of Investor Relations and Corporate Communications at Syros.